Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich-Heine-University, 40225, Düsseldorf, Germany.
Biological and Medical Research Center (BMFZ), Medical Faculty, Heinrich-Heine-University, Universitätsstraße 1, 40225, Duesseldorf, Germany.
Commun Biol. 2023 Apr 15;6(1):418. doi: 10.1038/s42003-023-04768-4.
All except one cytokine of the Interleukin (IL-)6 family share glycoprotein (gp) 130 as the common β receptor chain. Whereas Interleukin (IL-)11 signal via the non-signaling IL-11 receptor (IL-11R) and gp130 homodimers, leukemia inhibitory factor (LIF) recruits gp130:LIF receptor (LIFR) heterodimers. Using IL-11 as a framework, we exchange the gp130-binding site III of IL-11 with the LIFR binding site III of LIF. The resulting synthetic cytokimera GIL-11 efficiently recruits the non-natural receptor signaling complex consisting of gp130, IL-11R and LIFR resulting in signal transduction and proliferation of factor-depending Ba/F3 cells. Besides LIF and IL-11, GIL-11 does not activate receptor complexes consisting of gp130:LIFR or gp130:IL-11R, respectively. Human GIL-11 shows cross-reactivity to mouse and rescued IL-6R mice following partial hepatectomy, demonstrating gp130:IL-11R:LIFR signaling efficiently induced liver regeneration. With the development of the cytokimera GIL-11, we devise the functional assembly of the non-natural cytokine receptor complex of gp130:IL-11R:LIFR.
除了白细胞介素(IL-)6 家族的一种细胞因子外,其余细胞因子都与糖蛋白(gp)130 共享共同的β受体链。虽然白细胞介素(IL-)11 通过非信号转导的白细胞介素(IL-11)受体(IL-11R)和 gp130 同源二聚体信号转导,但白血病抑制因子(LIF)募集 gp130:LIF 受体(LIFR)异二聚体。我们以白细胞介素(IL-)11 为框架,用 LIF 的 LIFR 结合位点 III 替换白细胞介素(IL-)11 的 gp130 结合位点 III。由此产生的合成细胞因子 GIL-11 能够有效地募集由 gp130、IL-11R 和 LIFR 组成的非天然受体信号复合物,从而导致因子依赖性 Ba/F3 细胞的信号转导和增殖。除了 LIF 和 IL-11 之外,GIL-11 不会分别激活由 gp130:LIFR 或 gp130:IL-11R 组成的受体复合物。人 GIL-11 对小鼠和部分肝切除后挽救的 IL-6R 小鼠表现出交叉反应性,证明 gp130:IL-11R:LIFR 信号有效地诱导了肝再生。随着细胞因子 GIL-11 的发展,我们设计了 gp130:IL-11R:LIFR 非天然细胞因子受体复合物的功能组装。